SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCerillion Regulatory News (CER)

Share Price Information for Cerillion (CER)

Share Price is delayed by 15 minutes
Get Live Data
1,240.00    30.00 (2.46%)
Bid:
1,230.00
Ask:
1,250.00
Spread: 20.00 (1.626%)
Market Cap: £369.26m
CER Live PriceLast checked at - London Stock Exchange

Intraday Cerillion Share Chart

Replacement - Purchase, Options Exercise, Dividend

19 Nov 2024 14:07

RNS Number : 8395M
Cerillion PLC
19 November 2024
 

The following amendment has been made to the 'Share purchase for Long-Term Incentive Plan, exercise of options under LTIP, PDMR shareholdings and dividend declaration' announcement released on 19 November 2024 at 07:00 a.m. under RNS No 7006M. The final dividend amount under the 'Dividend Declaration - timing update' header has been corrected to 9.2p from 8.0p. All other details remain unchanged. The full amended text is shown below.

 

Cerillion plc

("Cerillion" or the "Company")

 

Share purchase for Long-Term Incentive Plan, exercise of options under LTIP, PDMR shareholdings and dividend declaration

 

Cerillion, the billing, charging and customer relationship management software solutions provider, announces that on 18 November, the Company purchased into treasury 32,500 shares of 0.5 pence each in the Company ("Ordinary Shares") at an average price of 1910 pence per Ordinary Share.

 

The 32,500 Ordinary Shares were immediately issued from treasury to certain members of senior management (set out below) who have exercised their rights pursuant to the Company's Long-Term Incentive Plan ("LTIP"), details of which were announced on 19 September 2017. These options, that are exercisable at the nominal value of the Ordinary Shares, were subject to the achievement of targets for compound annual growth in the share price of the Company over the original three-year vesting period.

 

PDMR

Role

LTIPs exercised

Alistair Carwardine

SVP Asia Pacific

5,000

Arif Bhavnagarwalla

Head of Operations, India

5,000

Mark Nicholls

Chief Operating Officer

7,500

Amit McCann

Account Development Director

5,000

Andrew Smith

Marketing Director

5,000

Richard Doughty

Business Development Director

5,000

 

The information below is set out in accordance with the requirements of the Market Abuse Regulation (EU) 596/2014 (which forms part of UK domestic law pursuant to the European Union (Withdrawal) Act 2018, as amended), provides further details of the transaction EU Market Abuse Regulation, provides further detail on the sales.

 

Treasury Shares

Following the transfer, the Company holds no shares in Treasury.

 

Total voting rights

Following the exercise of LTIPs, the total number of Ordinary Shares in issue, for the purposes of the Financial Conduct Authority's Disclosure and Transparency Rules, remains unchanged at 29,535,614 with each share carrying the right to one vote.

The above figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure and Transparency Rules.

 

Dividend Declaration - timing update

 

Further to the Company's final results for the year ended 30 September 2024, as announced on 18 November 2024, the Company provides an update on the proposed dividend timetable. The final dividend of 9.2p* per share, which is subject to shareholder approval at the Company's Annual General Meeting to be held on 13 February 2025, will be payable on 20 February 2025 to those shareholders on the Company's register as at the close of business on the record date of 17 January. The ex-dividend date is 16 January 2025.

 

 

Enquiries:

Cerillion plc

c/o KTZ Communications

Louis Hall, CEO

T: 020 3178 6378

Andrew Dickson, CFO

Panmure Liberum Limited (Nomad and Joint Broker)

T: 020 3100 2000

Bidhi Bhoma, Edward Mansfield, Freddie Wooding

Singer Capital Markets (Joint Broker)

T: 020 7496 3000

Rick Thompson, James Fischer

KTZ Communications

T: 020 3178 6378

Katie Tzouliadis, Robert Morton

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

Alistair Carwardine

Arif Bhavnagarwalla

Mark Nicholls

Amit McCann

Andrew Smith

Richard Doughty

2

Reason for the notification

a)

 

Position/status

SVP Asia Pacific

Head of Operations, India

Chief Operating Officer

Account Development Director

Marketing Director

Business Development Director

b)

 

Initial notification /Amendment

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

Cerillion PLC

b)

 

LEI

213800ISIZMUC3P46850

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  

a)

 

Description of the financial instrument, type of instrument

  Identification code

 

 Ordinary shares of GBP 0.005 each

GB00BYYX6C66

b)

 

Nature of the transaction

 

Exercise of options into Ordinary Shares under the LTIP

 

c)

 

Price(s) and volume(s)

 

 

  Price(s)

 

Volume(s)

0.5 pence

5,000

0.5 pence

5,000

0.5 pence

7,500

0.5 pence

5,000

0.5 pence

5,000

0.5 pence

5,000

 

d)

 

Aggregated information

- Aggregated volume

 - Price

 

32,500 Ordinary Shares

0.5 pence

 

e)

 

Date of the transaction

18 November 2024

f)

 

Place of the transaction

 

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFFSFLUELSESF
Date   Source Headline
7th Feb 20209:57 amRNSResult of AGM
8th Jan 20208:58 amRNSHolding(s) in Company
8th Jan 20207:00 amRNSNotice of AGM
27th Nov 20192:52 pmRNSHolding(s) in Company
25th Nov 20197:00 amRNSFinal Results
20th Nov 20197:00 amRNSHolding(s) in Company
28th Oct 20197:00 amRNSTrading Update
14th Oct 20197:00 amRNSMajor Contract Win
26th Sep 20194:49 pmRNSHolding(s) in Company
9th Sep 20197:00 amRNSMajor New Contract Win
8th Aug 20194:14 pmRNSHolding(s) in Company
8th Aug 20194:13 pmRNSHolding(s) in Company
28th Jun 20197:00 amRNSHolding(s) in Company
25th Jun 20197:00 amRNSMajor Contract Win
14th Jun 20197:00 amRNSMajor New Contract Win
20th May 20197:00 amRNSInterim Results
2nd May 20197:00 amRNSTrading Update and Notice of Results
21st Feb 20197:00 amRNSGartner Magic Quadrant Report
14th Feb 20194:01 pmRNSEmployee Share Option Scheme
13th Feb 20197:00 amRNSMajor New Contract Win
8th Feb 20193:16 pmRNSResult of AGM
25th Jan 20196:03 pmRNSNotice of AGM
26th Nov 20187:00 amRNSFinal Results
22nd Oct 20187:00 amRNSTrading Update
30th May 20187:00 amRNSTM Forum's 2018 Catalyst Awards
14th May 20187:00 amRNSInterim Results
16th Apr 20187:25 amRNSTrading Update & Notice of Results
5th Feb 201810:21 amRNSResult of AGM
17th Jan 20187:00 amRNSNotice of AGM and Posting of Annual Report
5th Dec 20177:00 amRNSMajor Contract Win
27th Nov 20177:00 amRNSFinal Results
17th Nov 20177:00 amRNSChange of Registered Office
30th Oct 20177:00 amRNSGartner Magic Quadrant Report
30th Oct 20177:00 amRNSTrading Update
20th Sep 20174:33 pmRNSHolding(s) in Company
19th Sep 20174:39 pmRNSImplementation of Long Term Incentive Plan
26th May 201710:13 amRNSCompletion of Director Placing
25th May 20175:00 pmRNSProposed Director Placing
22nd May 20177:00 amRNSInterim Results
9th May 20177:00 amRNSNotice of Results
10th Apr 20177:00 amRNSTrading Update
17th Mar 20177:00 amRNSMajor Contract Win
8th Feb 20174:11 pmRNSRe: New Employee Share Option Scheme
11th Jan 20175:47 pmRNSNotice of AGM and Posting of Annual Report
6th Jan 20177:00 amRNSNew Employee Share Option Scheme
21st Dec 20167:00 amRNSMajor Contract Win
1st Dec 20165:38 pmRNSRevised Dividend Timetable
28th Nov 20167:00 amRNSMajor Contract Win
28th Nov 20167:00 amRNSFinal Results
24th Oct 20167:00 amRNSRe: Gartner's 2016 Magic Quadrant report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.